Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NanoviricidesNNVC +24.65%34 Price-to-Tangible-Book is 4.33 as of Sep. 21, 2026. GuruFocus rates NNVC with a GF Score™ of 34/100. Among 1,133 Biotechnology companies, Nanoviricides ranks worse than 51.63% on this metric.
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Nanoviricides Price-to-Tangible-Book Related Terms
Nanoviricides Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for Nanoviricides's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NNVC vs ATNM, IGC, KYNB: Price-to-Tangible-Book Comparison
For the Biotechnology subindustry, Nanoviricides's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nanoviricides Price-to-Tangible-Book vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nanoviricides's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Nanoviricides's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Nanoviricides (NNVC) has a Price-to-Tangible-Book of 4.33 as of Sep. 21, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Nanoviricides and its competitors. According to the industry distribution chart, Nanoviricides ranks #585 out of 1133 companies in the Biotechnology industry, placing it in the top 51.6%.
Is Nanoviricides' Price-to-Tangible-Book too high?
Nanoviricides' current Price-to-Tangible-Book is 4.33. The Biotechnology industry median Price-to-Tangible-Book is 3.29. Nanoviricides' value of 4.33 is 31.6% above this industry median. Based on the distribution chart, Nanoviricides ranks #585 out of 1133 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Nanoviricides has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Nanoviricides' Price-to-Tangible-Book compare to ATNM and IGC?
According to the Biotechnology industry distribution chart, Nanoviricides ranks #585 out of 1133 companies for Price-to-Tangible-Book. This places Nanoviricides in the lower half of its industry. The industry median Price-to-Tangible-Book is 3.29. Nanoviricides' value of 4.33 is 31.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Biotechnology company?
The median Price-to-Tangible-Book among Biotechnology companies is 3.29, based on 1,133 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nanoviricides's current Price-to-Tangible-Book of 4.33 is 31.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Nanoviricides and its competitors. For the Biotechnology industry, the median Price-to-Tangible-Book is 3.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nanoviricides's current Price-to-Tangible-Book is 4.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanoviricides stock overvalued right now?
Nanoviricides (NNVC) has a current Price-to-Tangible-Book of 4.33. The current Price-to-Tangible-Book is 4.33 and 31.6% above the Biotechnology industry median of 3.29. Nanoviricides' overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For Nanoviricides (NNVC), the current Price-to-Tangible-Book is 4.33 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
34GF Score
Get the complete analysis for NNVC
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NNVC has been successfully added to your 
